A randomized, double-blind, placebo-controlled, multicentre study to assess haemodynamic effects of serelaxin in patients with acute heart failure
Articolo
Data di Pubblicazione:
2014
Abstract:
The aim of this study was to evaluate the haemodynamic effects of serelaxin (30 µg/kg/day 20-h infusion and 4-h post-infusion period) in patients with acute heart failure (AHF).
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
Acute heart failure; Clinical trial; Haemodynamics; Serelaxin; Aged; Analysis of Variance; Blood Pressure; Cardiotonic Agents; Double-Blind Method; Female; Glomerular Filtration Rate; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Pulmonary Wedge Pressure; Recombinant Proteins; Relaxin; Vascular Resistance
Elenco autori:
Ponikowski, Piotr; Mitrovic, Veselin; Ruda, Mikhail; Fernandez, Alberto; Voors, Adriaan A; Vishnevsky, Alexander; Cotter, Gad; Milo, Olga; Laessing, Ute; Zhang, Yiming; Dahlke, Marion; Zymlinski, Robert; Metra, Marco
Link alla scheda completa:
Pubblicato in: